Salzburg, Austria

Olaf Haubenreisser

This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Other. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Olaf Haubenreisser. Retrieved from https://idiyas.com/inventor/olaf-haubenreisser

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0


 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:

goldMedal1 out of 834,453 
Other
 patents

Years Active: 2024

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Olaf Haubenreisser

Introduction

Olaf Haubenreisser is an inventor based in Sulz im Wienerwald, Austria. He has made significant contributions to the field of biotechnology, particularly in the area of gene translation. Although he currently holds no granted patents, his work is noteworthy for its potential applications in medical and cosmetic fields.

Latest Patent Applications

One of his notable patent applications is titled "Method for Identifying Interventions that Control the Translational Activity of Ribosomal Proteins in Differential mRNA Expression." This invention relates to systems and methods for screening compounds and/or mutant ribosomal proteins in a eukaryotic cell. The goal is to increase or decrease the translation of a target gene, thereby ameliorating or reverting defective and/or undesired translation. The application discusses various compounds and proteins identified through these methods, as well as their uses in preparing medicaments and treating genetic diseases such as Epidermolysis bullosa. Additionally, it includes diagnostic measures for clinical evaluation and kits comprising the identified compounds and/or proteins.

Conclusion

Olaf Haubenreisser's innovative work in gene translation highlights the importance of research in biotechnology. His contributions, although not yet patented, have the potential to impact medical treatments and diagnostics significantly.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…